Amneal
AMRX
Performance
About Amneal
Amneal is a pharmaceutical company with a broad portfolio of generic and specialty medicines, including biosimilars and oncology therapies. It emphasizes research, manufacturing, and distribution capabilities to expand access to affordable medicines across the United States and international markets. The company highlights its mission to make healthy possible and operates through a diversified portfolio spanning generics, specialty products, and biosciences. Headquartered in the United States, Amneal serves patients and healthcare institutions worldwide.
Recent News
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
Apothecon Group Names Shyamakant Giri CEO to Drive Specialty Formulations Growth
Amneal to Buy a Biosimilar Company; Samsung Bio Workers Protest
Amneal Secures FDA Approval for Romidepsin Injection, Gaining 180-Day Exclusivity
Piyush Goyal Engages with over 50 Industry Leaders in New York to Deepen India-US Trade